Where does Enzo Life Sciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Enzo Life Sciences, Inc. ranks #6,140 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Enzo Life Sciences, Inc. hold?

Enzo Life Sciences, Inc. holds 55 US utility patents granted between 2015 and 2024, spanning 16 technology areas.

What is Enzo Life Sciences, Inc.'s Innovation Score?

Enzo Life Sciences, Inc. has an Innovation Score of 42.8 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Enzo Life Sciences, Inc.'s patent grant rate increasing or decreasing?

Enzo Life Sciences, Inc.'s recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Enzo Life Sciences, Inc.'s patents?

Enzo Life Sciences, Inc.'s patents average 21.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Enzo Life Sciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Enzo Life Sciences, Inc.

Q: What technology areas does Enzo Life Sciences, Inc. focus on?

Enzo Life Sciences, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 47 patents, ranking #102 of 2,502 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 55 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Enzo ranks #6,140 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 16 technology areas.

#6,140
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.8/100): 21.8
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6140 · US Corporation #6,140 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,140/49,997
PHOTO-FINISH Dental Imaging
CPC-FOCUS C12Q · 16 areas
INNOV-PAR 42.8/100
CLAIMS-DENSE 21.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dental Imaging Technologies Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Enzo’s 42.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (32%) Velocity 1.7 pts (4%) Breadth 14.1 pts (33%) Claim depth 13.1 pts (31%)

Qualcomm Incorporated · highest

85
Bandai Namco… · near

43
Cal-comp BIG Data · near

43
Daishinku · near

43
Enzo Life Sciences · this assignee

43
Pierburg · near

43
3D Lighting… · lowest

7

What this shows Enzo's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Enzo?

Each dot is one of Enzo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Enzo’s own 21.8 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Enzo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Enzo's grants concentrate

Enzo Life Sciences, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 85.5% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2016 (15 grants) versus a trough of 1 in 2023. By volume, Enzo sits between Dental Imaging Technologies Corporation and Entellus Medical, Inc..

Enzo's three-year grant acceleration

Enzo Life Sciences, Inc. shows 4 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Dental Imaging

55
DT Swiss

55
Dyax

55
Elkay Manufacturi…

55
Eugene Technology

55
East Carolina Uni…

55
Ellenberger & Poe…

55
Entellus Medical

55
Enzo Life Sciences ◀

55

What this shows Enzo holds 55 patents at rank #6,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Enzo

By rank, the assignees closest to #6,137 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Enzo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Enzo, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Enzo ranks #102 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (43 here).

Daishinku Corporation 43 Cal-comp BIG Data, Inc. 43 Pierburg GMBH 43 Bandai Namco Entertainment Inc. 43

Similar claim depth

Nearest assignees by average claims per patent (21.8 here).

Invuity, Inc. 21.8 avg Dexterity, Inc. 21.8 avg Astex Therapeutics Limited 21.8 avg Shape Security, Inc. 21.8 avg

Enzo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Enzo Life Sciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	12.7%
2016	15	27.3%
2017	8	14.5%
2018	5	9.1%
2019	5	9.1%
2020	6	10.9%
2021	5	9.1%
2023	1	1.8%
2024	3	5.5%

Which technologies does Enzo Life Sciences, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 47

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 47

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 26

C07D - Heterocyclic Compounds 18

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 15

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 14

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 14

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 13

C12Y - Enzymes 8

C07K - Peptides 6

C07C - Acyclic OR Carbocyclic Compounds 4

C07J - Steroids 3

C09K - Materials FOR Miscellaneous Applications, NOT Provided FOR Elsewhere 3

Y10T - Technical Subjects Covered BY Former US Classification 3

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Enzo Life Sciences, Inc.'s patent record in context - here's where to go next.

Enzo Life Sciences, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 85.5% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,140 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Enzo Life Sciences, Inc. against Dental Imaging Technologies Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.